Form 4: BNBX Director Acquires 18,691 Shares

APPLIED DNA SCIENCES Director Judith Murrah acquired 18,691 shares of common stock on October 17, 2025, increasing her beneficial ownership to 18,694 shares.

Summary

• Judith Murrah, a Director of APPLIED DNA SCIENCES INC (BNBX), acquired 18,691 shares of common stock.
• The transaction occurred on October 17, 2025, at a price of $0 per share, indicating a grant of restricted stock units.
• Following this acquisition, Ms. Murrah's direct beneficial ownership increased to 18,694 shares of common stock.
• The acquired shares are restricted stock units, with 100% vesting 90 days from the date of grant.

Sentiment

Score: 6

Explanation: Slightly positive due to increased insider ownership, indicating confidence, although it's a compensation grant rather than an open market purchase.

Positives

• Increased direct beneficial ownership by a Director, which can signal confidence in the company's future.
• The grant of restricted stock units aligns the Director's interests with long-term shareholder value.

Risks

• The acquired shares are restricted stock units, meaning their value is contingent on future vesting conditions and the company's stock performance.
• The vesting period of 90 days from the grant date means the shares are not immediately liquid.

Future Outlook

The acquired restricted stock units are expected to vest 100% upon 90 days from the grant date, which is estimated to be January 15, 2026.

Industry Context

This filing reports a routine insider equity compensation event for a director, common across publicly traded companies to align management and director incentives with shareholder interests.

Related Party Transactions

• Acquisition of 18,691 shares of common stock by Director Judith Murrah as part of an equity compensation plan.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholder value through equity ownership.
• Management: Standard equity compensation for a director.

Next Steps

• Vesting of the 18,691 restricted stock units 90 days from the grant date (estimated January 15, 2026).

Key Dates

Keywords

APPLIED DNA SCIENCES, BNBX, Insider Transaction, Form 4, Director, Stock Acquisition, Restricted Stock Units, Equity Compensation